151. Creutzfeldt-Jakob disease in pregnancy: the use of modified RT-QuIC to determine infectivity in placental tissues
- Author
-
Collin Luk, Christina D. Orrù, Byron Caughey, Gerard H. Jansen, Valerie L. Sim, Candace K. Mathiason, and Allison Thiele
- Subjects
0301 basic medicine ,Adult ,Amniotic fluid ,Prions ,Placenta ,Creutzfeldt–Jakob disease ,Physiology ,Autopsy ,Case Report ,Disease ,Biochemistry ,Creutzfeldt-Jakob Syndrome ,Prion Proteins ,prion ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,0302 clinical medicine ,Pregnancy ,Report ,medicine ,Humans ,Rt-QuIC ,business.industry ,Gestational age ,Cell Biology ,medicine.disease ,030104 developmental biology ,Infectious Diseases ,medicine.anatomical_structure ,Cord blood ,Gestation ,Biological Assay ,Female ,vertical transmission ,business ,030217 neurology & neurosurgery - Abstract
Sporadic Creutzfeldt–Jakob Disease (sCJD) rarely affects women of childbearing age. There is currently no evidence of vertical transmission. Given the biosafety implications of performing Caesarean sections (C-section) in these patients, we used sensitive real-time quaking-induced conversion (RT-QuIC) assays to test for the infectious prion protein (PrPSc) in products of gestation. A 35-year-old woman with sCJD presented in her 10th gestational week with an eight month history of progressive cognitive impairment. During C-section, amniotic fluid, cord blood and placental tissue were collected and analysed using RT-QuIC protocols adapted for use with these tissues. The patient’s diagnosis of sCJD, MM2 subtype, was confirmed at autopsy. There were borderline positive results in one sampled area of the placenta, but otherwise the cord blood and amniotic fluid were negative on our RT-QuIC assays. A healthy baby was delivered via C-section at 36 weeks and 3 days gestational age, with no evidence of neurological disease to date. We conclude that precautions should be taken with products of gestation, but the level of PrPSc is extremely low.
- Published
- 2021